Peter Vozzo | Investor Relations Representative |
Jerry Jabbour | Chief Executive Officer |
Dr. Terry Matkovits | Chief Development Officer |
Keith Kucinski | Chief Financial Officer |
Dr. Raphael Mannino | Chief Scientific Officer |
Dr. Terry Ferguson | Chief Medical Officer |
Thomas Hoover | Chief Business Officer |
Bert Hazlett | BTIG |
Hello. And welcome to the Matinas BioPharma Second Quarter 2022 Results Conference Call. At this time, all participants are in listen-only mode. A question-and-answer session will follow the formal presentation.
As a reminder, this conference is being recorded.